Search Clinical Trials Search
Clinical Trials
× ...
Sort & Filter
Sort by
Specialty

Disease or Condition

Age Group


Drug/Medication


156 results found


Urinary Bladder

SWOG, S2427, Ph2, Open-Label, Muscle Invasive Bladder Cancer, Radiotherapy (RT) + pembrolizumab

1.1 Primary Objective a. To evaluate whether 3-year bladder intact event-free survival (BI-EFS) is at least 70% in participants with clinically T0-clinically T1 without multifocal CIS following neoadjuvant therapy (NAT) for muscle-invasive bladder cancer (MIBC) who ...